Flap endonuclease 1 repairs DNA-protein cross-links via ADP-ribosylation–dependent mechanisms
Science Advances · 10.01.2025 · 11 (2)
DOI: 10.1126/sciadv.ads2919 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 10.01.2025. Verfasst von Yilun Sun und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Physiology and Drug Development, University of Maryland School of Medicine, Baltimore, MD 21201, USA. Hauptthemen laut MEDLINE: Flap Endonucleases, DNA Repair, Poly (ADP-Ribose) Polymerase-1, DNA. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, NIGMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
DNA-protein cross-links (DPCs) are among the most detrimental genomic lesions. They are ubiquitously produced by formaldehyde (FA), and failure to repair FA-induced DPCs blocks chromatin-based processes, leading to neurodegeneration and cancer. The type, structure, and repair of FA-induced DPCs remain largely unknown. Here, we profiled the proteome of FA-induced DPCs and found that flap endonuclease 1 (FEN1) resolves FA-induced DPCs. We revealed that FA also damages DNA bases adjoining the DPCs, leading to DPC-conjugated 5′ flap structures via the base excision repair (BER) pathway. We also found that FEN1 repairs enzymatic topoisomerase II (TOP2)–DPCs. Furthermore, we report that both FA-induced and TOP2-DPCs are adenosine diphosphate (ADP) ribosylated by poly(ADP-ribose) polymerase 1 (PARP1). PARylation of the DPCs in association with FEN1 PARylation at residue E285 is required for the recruitment of FEN1. Our work unveils the identity of proteins forming FA-induced DPCs and a previously unrecognized PARP1-FEN1 nuclease pathway repairing both FA- and TOP2-DPCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Physiology and Drug Development, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
- University of Maryland Marlene and Stewart Greenebaum NCI Comprehensive Cancer Center, Baltimore, MD 21201, USA.
- Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA.
- Mass Spectrometry Section, Collaborative Protein Technology Resource, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA.
- Function Genomics Laboratory, National Center for Advancing Translational Sciences, National Institute of Health, Rockville, MD 20850, USA.
- Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.
ORCID-Profile: Yilun Sun, Lisa M Jenkins, Linying Zhu, Xi Yang, Ukhyun Jo, Tapan K Maity, Isabel Uribe, Shunichi Takeda, Anthony K L Leung, Ken Cheng, Yves Pommier
Förderung
- Intramural NIH HHS
- NIGMS NIH HHS
- NCI NIH HHS
Zitieren
APA
Sun, Y., Jenkins, L. M., El Touny, L. H., Zhu, L., Yang, X., Jo, U., Escobedo, L., Maity, T. K., Saha, L. K., Uribe, I., Saha, S., Takeda, S., Leung, A. K. L., Cheng, K., & Pommier, Y. (2025). Flap endonuclease 1 repairs DNA-protein cross-links via ADP-ribosylation–dependent mechanisms. Science Advances, 11(2). https://doi.org/10.1126/sciadv.ads2919
Vancouver
Sun Y, Jenkins LM, El Touny LH, Zhu L, Yang X, Jo U, et al. Flap endonuclease 1 repairs DNA-protein cross-links via ADP-ribosylation–dependent mechanisms. Science Advances. 2025;11(2). doi:10.1126/sciadv.ads2919
BibTeX
@article{Sun2025,
author = {Sun, Yilun and Jenkins, Lisa M and El Touny, Lara H and Zhu, Linying and Yang, Xi and Jo, Ukhyun and Escobedo, Lauren and Maity, Tapan K and Saha, Liton Kumar and Uribe, Isabel and Saha, Sourav and Takeda, Shunichi and Leung, Anthony K L and Cheng, Ken and Pommier, Yves},
title = {Flap endonuclease 1 repairs DNA-protein cross-links via ADP-ribosylation–dependent mechanisms},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {2},
doi = {10.1126/sciadv.ads2919}
}
EUVIMED